Allergan Plc Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Allergan Plc are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Low | High |
Very Weak
Over the last 90 days Allergan Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Allergan Plc is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Fifty Two Week Low | 158.67 | |
Target High Price | 203.00 | |
Fifty Two Week High | 202.21 | |
Trailing Annual Dividend Yield | 1.53% | |
Target Low Price | 157.00 |
Allergan |
Allergan Plc Relative Risk vs. Return Landscape
If you would invest (100.00) in Allergan Plc on December 30, 2023 and sell it today you would earn a total of 100.00 from holding Allergan Plc or generate -100.0% return on investment over 90 days. Allergan Plc is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Allergan, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
Allergan Plc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Allergan Plc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Allergan Plc, and traders can use it to determine the average amount a Allergan Plc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
AGN |
Based on monthly moving average Allergan Plc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Allergan Plc by adding Allergan Plc to a well-diversified portfolio.
Allergan Plc Fundamentals Growth
Allergan Stock prices reflect investors' perceptions of the future prospects and financial health of Allergan Plc, and Allergan Plc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Allergan Stock performance.
Return On Equity | -0.0913 | |||
Return On Asset | -0.0564 | |||
Current Valuation | 81.41 B | |||
Shares Outstanding | 328.1 M | |||
Price To Earning | 24.00 X | |||
Price To Book | 1.07 X | |||
Price To Sales | 3.95 X | |||
Revenue | 15.82 B | |||
EBITDA | 7.11 B | |||
Cash Per Share | 13.88 X | |||
Debt To Equity | 39.40 % | |||
Cash Flow From Operations | 6.47 B | |||
Earnings Per Share | (27.98) X | |||
Total Asset | 135.58 B | |||
Retained Earnings | 1.02 B | |||
Current Asset | 8.58 B | |||
Things to note about Allergan Plc performance evaluation
Checking the ongoing alerts about Allergan Plc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Allergan Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Allergan Plc is not yet fully synchronised with the market data | |
Allergan Plc has some characteristics of a very speculative penny stock | |
Allergan Plc has a very high chance of going through financial distress in the upcoming years | |
The company reported the last year's revenue of 15.82 B. Reported Net Loss for the year was (9.25 B) with profit before taxes, overhead, and interest of 13.65 B. | |
Over 98.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Allergan Plc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Allergan Plc's stock is overvalued or undervalued compared to its peers.
- Examining Allergan Plc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Allergan Plc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Allergan Plc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Allergan Plc's stock. These opinions can provide insight into Allergan Plc's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Allergan Plc information on this page should be used as a complementary analysis to other Allergan Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Allergan Stock
If you are still planning to invest in Allergan Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allergan Plc's history and understand the potential risks before investing.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |